Development of a core outcome set for disease modification trials in mild to moderate dementia: a systematic review, patient and public consultation and consensus recommendations
Lucy Webster(University College London), Gill Livingston(North East London NHS Foundation Trust)
Cited by 73
Related Papers
Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
|The Lancet|2024|2.8k